- $41.39m
- $148.50m
- $458.51m
U.S. RESEARCH ROUNDUP-Accuray, Aevex, Zoetis
Accuray withdraws outlook as Q3 revenue falls, loss widens
Brief: Accuray Incorporated Q3 Revenue USD 104.845 Million
Accuray Q2 revenue falls 12%, swings to net loss
Brief: Accuray Inc Says Workforce Optimization Actions Will Affect Approximately 15% Of Company's Employees
Radiation therapy systems firm Accuray Q1 revenue down 7%, net loss widens
Brief: Accuray Incorporated Reports Inducement Award Under Nasdaq Listing Rules
Brief: Accuray Announces Milestone For Cancer Patients In Melbourne, Australia With First Sbrt Treatments Using The Cyberknife® System
Accuray Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: Accuray Incorporated Q4 Revenue USD 127.543 Million Vs. IBES Estimate USD 123.8 Million
Accuray Inc expected to post earnings of 2 cents a share - Earnings Preview
Brief: Accuray Announces Convertible Notes Exchange And Refinancing Of Existing Credit Facilities
Accuray Inc reports results for the quarter ended March 31 - Earnings Summary
Accuray Inc expected to post a loss of 5 cents a share - Earnings Preview
Accuray Inc reports results for the quarter ended December 31 - Earnings Summary
Accuray Inc expected to post a loss of 2 cents a share - Earnings Preview
Brief: Accuray Says Radixact SynC System, CyberKnife S7 System Approved By Chinese National Medical Products Administration
Brief: Accuray Incorporated Reports Inducement Award Under Nasdaq Listing Rules
Accuray Inc reports results for the quarter ended in September 30 - Earnings Summary